TSHA

Taysha Gene Therapies, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$4.37

Market Cap

$1.09B

Beta

1.08

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+17.28%

EPS Growth (YoY)+9.07%

Revenue CAGR 3Y+57.49%

P/E Ratio0.0

PEG Ratio—

FCF Yield-8.58%

Debt / Equity0.07

Interest Coverage-1753.9x

No credit card required

Already have an account? Sign in to view the full analysis for TSHA.